In addition to being a clinician, Prof. Frauke Alves has a long standing track record in translational multiscale imaging approaches in oncology. She heads a research group based at the Clinic of Hematology and Medical Oncology and at the Institute of Diagnostic and Radiology at the University Medicine Center as well as at the Max-Planck-Institute for Experimental Medicine in Goettingen, Germany, facilitating the translation of basic knowledge into clinical practice in the field of oncology for the benefit of the patient. The focus of her interdisciplinary molecular imaging group is the investigation of mechanisms of tumor progression, angiogenesis and inflammation as well as the development and validation of novel nanoparticle based therapeutic and diagnostic strategies using orthotopic metastatic and transgenic tumor mouse models in combination with non-invasive optical and x-ray based imaging techniques and probes. Prof. Alves is a member of several national and EU large grant consortia. In 2020 she will be the President of the European Society of Molecular Imaging (ESMI).